Abiopharma

🔍 BENKOWITZ MICHAEL (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 14,625 shares of Common Stock at $135.42 per share (Direct)
  Date: 2025-09-02 | Code: M | equity_swap_involved: false | shares_owned_after: 14,625.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 11,375 shares of Common Stock at $419.63 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 3,250.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 106 shares of Common Stock at $405.5949 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 3,144.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 500 shares of Common Stock at $407.3371 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 2,644.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 700 shares of Common Stock at $408.9721 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 1,944.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 1,144 shares of Common Stock at $409.9698 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 800.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 168 shares of Common Stock at $412.6942 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 632.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 32 shares of Common Stock at $413.3869 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 600.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 200 shares of Common Stock at $416.3036 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 400.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 328 shares of Common Stock at $418.0307 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 72.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 72 shares of Common Stock at $419.3514 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Acquired 7,875 shares of Common Stock at $146.03 per share (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: false | shares_owned_after: 7,875.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 888 shares of Common Stock at $407.2642 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,987.00 | transaction_form_type: 4 | Footnotes: F1, F13, F12
• Sold 300 shares of Common Stock at $408.2758 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,687.00 | transaction_form_type: 4 | Footnotes: F1, F14, F12
• Sold 100 shares of Common Stock at $410.35 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,587.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 367 shares of Common Stock at $417.4501 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,220.00 | transaction_form_type: 4 | Footnotes: F1, F15, F12
• Sold 95 shares of Common Stock at $419.6094 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 6,125.00 | transaction_form_type: 4 | Footnotes: F1, F16, F12
• Sold 6,125 shares of Common Stock at $419.63 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | shares_owned_after: 2,648.00
• Sold 14,625 shares of Stock Options at $135.42 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 172,875.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,875 shares of Stock Options at $146.03 per share (Derivative)
  Date: 2025-09-02 | Code: M | Expires: 2027-03-15 | Exercise: 2018-03-15 | equity_swap_involved: false | shares_owned_after: 55,125.00 | transaction_form_type: 4 | Footnotes: F1, F12

Footnotes:

• F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.
• F2: Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
• F3: This transaction was executed in multiple trades at prices ranging from $405.54 to $406.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $407.20 to $407.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $408.39 to $409.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $409.48 to $410.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $412.34 to $413.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $413.35 to $413.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $416.24 to $416.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F10: This transaction was executed in multiple trades at prices ranging from $417.74 to $418.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $418.77 to $419.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
• F13: This transaction was executed in multiple trades at prices ranging from $407.20 to $407.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $408.22 to $408.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: This transaction was executed in multiple trades at prices ranging from $417.20 to $417.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F16: This transaction was executed in multiple trades at prices ranging from $418.65 to $419.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.